Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,001 | 17 | 98.9% |
| Education | $11.56 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $733.35 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $136.37 | 2 | $0 (2022) |
| PFIZER INC. | $72.04 | 1 | $0 (2017) |
| Lilly USA, LLC | $22.97 | 1 | $0 (2021) |
| Dexcom, Inc. | $22.39 | 1 | $0 (2023) |
| Novo Nordisk Inc | $13.48 | 1 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $11.79 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $422.24 | 7 | Gilead Sciences, Inc. ($422.24) |
| 2023 | $333.50 | 5 | Gilead Sciences, Inc. ($311.11) |
| 2022 | $124.81 | 1 | AstraZeneca Pharmaceuticals LP ($124.81) |
| 2021 | $34.53 | 2 | Lilly USA, LLC ($22.97) |
| 2020 | $13.48 | 1 | Novo Nordisk Inc ($13.48) |
| 2017 | $83.83 | 2 | PFIZER INC. ($72.04) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $120.84 | General |
| 06/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.30 | General |
| 05/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.68 | General |
| 05/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.37 | General |
| 03/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $109.85 | General |
| 02/22/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: HCV | ||||||
| 02/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.61 | General |
| 12/06/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.43 | General |
| 11/30/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $84.17 | General |
| 10/24/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $171.61 | General |
| 10/23/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $35.90 | General |
| 05/25/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Endocrinology | ||||||
| 09/28/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/07/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $11.56 | General |
| Category: Respiratory | ||||||
| 02/10/2021 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Diabetes | ||||||
| 03/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Diabetes | ||||||
| 05/17/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $72.04 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 52 | 62 | $17,563 | $2,845 |
| 2022 | 5 | 182 | 203 | $51,627 | $13,558 |
| 2021 | 2 | 41 | 41 | $1,402 | $954.68 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 42 | $17,043 | $2,677 | 15.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 18 | 20 | $520.00 | $168.00 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 103 | $40,375 | $9,996 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 31 | $8,429 | $1,862 | 22.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 15 | 15 | $1,095 | $1,028 | 93.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $936.00 | $550.62 | 58.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 35 | 36 | $792.00 | $122.05 | 15.4% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 21 | 21 | $894.18 | $606.48 | 67.8% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 20 | 20 | $508.20 | $348.20 | 68.5% |
About Dr. Jane Park, M.D
Dr. Jane Park, M.D is a Pediatrics healthcare provider based in North Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2013. The National Provider Identifier (NPI) number assigned to this provider is 1790129898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jane Park, M.D has received a total of $1,012 in payments from pharmaceutical and medical device companies, with $422.24 received in 2024. These payments were reported across 18 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,001).
As a Medicare-enrolled provider, Park has provided services to 275 Medicare beneficiaries, totaling 306 services with total Medicare billing of $17,358. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location North Fort Myers, FL
- Active Since 04/19/2013
- Last Updated 03/29/2021
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1790129898
Products in Payments
- FARXIGA (Drug) $124.81
- Epclusa (Drug) $123.59
- EUCRISA (Drug) $72.04
- TRULICITY (Drug) $22.97
- Dexcom G6 Transmitter (Medical Supply) $22.39
- Ozempic (Drug) $13.48
- BELSOMRA (Drug) $11.79
- BREZTRI (Drug) $11.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.